Monoclonal antibody "cocktail" blocks COVID-19 variants: Study
A monoclonal antibody "cocktail" developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature Medicine.
That was one of the findings reported by a multi-institutional team led by researchers at Washington University School of Medicine in St. Louis.
In cell-culture studies, the researchers determined the ability of monoclonal antibodies as well as antibodies isolated from the "convalescent plasma" of previously infected people to neutralize highly transmissible variants of the SARS-CoV-2 virus that have arisen in the United Kingdom, South Africa, Brazil and elsewhere.
In general, most of the monoclonal antibodies that have ...














